Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04489225 · ClinicalTrials.gov registry record
Personalized Therapy Study - HFRS (TriageHF) Post Approval Study
A clinical trial of Heart Failure, sponsored by Medtronic.
- Active
- Registry status
- 2,200
- Enrollment target
- 20
- Study locations
NCT04489225 is a study of Heart Failure that is active but no longer recruiting, run by Medtronic. The registered enrollment target is 2,200 participants, roughly in line with the 2,043-participant average among 397 other Heart Failure trials with a reported enrollment target. The trial reports 20 study locations across 11 states.
The verdict
NCT04489225, a study of Heart Failure, is active but no longer recruiting, sponsored by Medtronic.
- ACTIVE NOT RECRUITING
- Registry status
- 2,200 participants
- Enrollment target
- 20
- Study locations
Study Summary
Medtronic is sponsoring the HFRS PAS to evaluate the HFRS feature (TriageHF) when used in routine clinical practice following commercial release. The HFRS PAS is conducted within Medtronic's Product Surveillance Registry (PSR) platform.
Conditions Studied
Interventions
- OTHER Observational
Study Locations (20)
Florida
- Heart Rhythm Solutions - Hollywood
- Baptist Health - Jacksonville
- Cardiovascular Institute of Northwest Florida - Panama City
- Heart & Vascular Institute of Florida - Safety Harbor
- Heart Rhythm Consultants P.A. (Sarasota Memorial Research) - Sarasota
California
- Chula Vista Cardiac Center - Chula Vista
- Cardiovascular Consultants Medical Group - Van Nuys
- Cardiology Associates Medical Group - Ventura
Colorado
- Colorado Springs Cardiology - Colorado Springs
- Denver Heart - Denver
- Colorado Heart and Vascular, PC - Lakewood
Connecticut
- Hartford Hospital - Hartford
- Yale New Haven Hospital - New Have
Arizona
- Southwest EP - Chandler
Arkansas
- Saint Vincent Heart Clinic Arkansas - Little Rock
Indiana
- Deaconess Specialty Physicians - Evansville
Iowa
- Iowa Heart - Des Moines
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,200 participants |
| Start Date | 2020-08-01 |
| Est. Completion | 2028-01-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04489225
The ClinicalTrials.gov registry entry for NCT04489225 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 2,200 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 2,043-participant average among 397 other Heart Failure trials with a reported enrollment target. The listed sponsor is Medtronic, which has 30 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which Observational is the first listed.
NCT04489225 reports 20 study locations spanning 11 distinct geographic areas - top geographies include Florida, California, Colorado.
Frequently Asked Questions
What is clinical trial NCT04489225 about?
NCT04489225 is a clinical study titled "Personalized Therapy Study - HFRS (TriageHF) Post Approval Study". Medtronic is sponsoring the HFRS PAS to evaluate the HFRS feature (TriageHF) when used in routine clinical practice following commercial release. The HFRS PAS is conducted within Medtronic's Product Surveillance Registry (PSR) platform.
What is the current status of trial NCT04489225?
This trial is currently active not recruiting. The enrollment target is 2,200 participants. The study started on 2020-08-01. Estimated completion is 2028-01-31.
What conditions does trial NCT04489225 study?
This clinical trial studies the following conditions: Heart Failure.
What interventions are being tested in trial NCT04489225?
The interventions under investigation include: Observational (OTHER).
Who is sponsoring clinical trial NCT04489225?
This trial is sponsored by Medtronic, which has 30 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04489225 being conducted?
This trial has 20 study locations across Arizona, Arkansas, California, Colorado, Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists
RECRUITING · Phase 3
-
Circulating Markers That Underlie the Transition From Compensated Hypertrophy to Heart Failure
RECRUITING
-
Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.